Literature DB >> 10593389

Patients with stages III and IV endometriosis have a poorer outcome of in vitro fertilization-embryo transfer than patients with tubal infertility.

F Azem1, J B Lessing, E Geva, A Shahar, L Lerner-Geva, I Yovel, A Amit.   

Abstract

OBJECTIVE: To evaluate the outcome of IVF in patients with stages III and IV endometriosis.
DESIGN: Retrospective study.
SETTING: The Sara Racine IVF Unit, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Israel. PATIENT(S): Fifty-eight patients with stages III and IV endometriosis and 60 patients with tubal infertility. INTERVENTION(S): IVF-ET for all couples. MAIN OUTCOME MEASURE(S): Fertilization, pregnancy, and birth rates. RESULT(S): The comparison between patients with endometriosis and those with tubal infertility indicated that the former had a poor IVF outcome in terms of reduced fertilization rate (40% vs. 70%), reduced pregnancy rate per cycle (10.6% vs. 22.4%), and reduced birth rate per cycle (6.7% vs. 16.6%). The differences were statistically significant. CONCLUSION(S): The results show an unfavorable outcome of IVF-ET in patients with endometriosis when compared with those who have tubal infertility.

Entities:  

Mesh:

Year:  1999        PMID: 10593389     DOI: 10.1016/s0015-0282(99)00392-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Conventional IVF versus ICSI in sibling oocytes from couples with endometriosis and normozoospermic semen.

Authors:  Alisa Komsky-Elbaz; Arieh Raziel; Shevach Friedler; Deborah Strassburger; Esti Kasterstein; Daphna Komarovsky; Raphael Ron-El; Ido Ben-Ami
Journal:  J Assist Reprod Genet       Date:  2012-12-28       Impact factor: 3.412

Review 2.  Does surgical management of endometriosis within 6 months of an in vitro fertilization-embryo transfer cycle improve outcome?

Authors:  Eric S Surrey; William B Schoolcraft
Journal:  J Assist Reprod Genet       Date:  2003-09       Impact factor: 3.412

3.  A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis.

Authors:  Hiroshi Tamura; Akihisa Takasaki; Yasuhiko Nakamura; Fumitaka Numa; Norihiro Sugino
Journal:  J Ovarian Res       Date:  2014-10-21       Impact factor: 4.234

4.  Effect of Natural Cycle Endometrial Preparation for Frozen-Thawed Embryo Transfer in Patients with Advanced Endometriosis.

Authors:  Haiyan Guo; Yun Wang; Qiuju Chen; Weiran Chai; Qifeng Lv; Yanping Kuang
Journal:  Med Sci Monit       Date:  2016-11-27

5.  Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.

Authors:  Ektoras X Georgiou; Pedro Melo; Philip E Baker; Hassan N Sallam; Aydin Arici; Juan A Garcia-Velasco; Ahmed M Abou-Setta; Christian Becker; Ingrid E Granne
Journal:  Cochrane Database Syst Rev       Date:  2019-11-20

6.  Preoperative serum anti-mullerian hormone level in women with ovarian endometrioma and mature cystic teratoma.

Authors:  Ju Yeong Kim; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

7.  Impact of the endometrioma on ovarian response and pregnancy rate in in vitro fertilization cycles.

Authors:  Mahnaz Ashrafi; Taravat Fakheri; Kiandokht Kiani; Maria Sadeghi; Mohammad Reza Akhoond
Journal:  Int J Fertil Steril       Date:  2014-03-09

8.  Selecting the embryo with the highest implantation potential using a data mining based prediction model.

Authors:  Fang Chen; Diane De Neubourg; Sophie Debrock; Karen Peeraer; Thomas D'Hooghe; Carl Spiessens
Journal:  Reprod Biol Endocrinol       Date:  2016-03-03       Impact factor: 5.211

9.  EFFECT OF PELVIC ENDOMETRIOSIS, ENDOMETRIOMAS AND RECURRENT ENDOMETRIOMAS ON IVF-ET/ICSI OUTCOMES.

Authors:  Weijie Xing; Haiyan Lin; Zexuan Wu; Yu Li; Qingxue Zhang
Journal:  Mater Sociomed       Date:  2016-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.